PharmaTimesNews & Politicsnews

First patient treated in new heavy‑chain‑only antibody trial

Monday, August 17, 2026John PinchingView original

Study begins testing KJ‑103 in TROP2‑positive cancers

Read the full article on the original site.

Read Full Article